Showing results (181-190 of 1,806) with videos related to

Sort By:
Pageof 181
Transplantation and Cellular Therapy|April 12, 2021
Outcomes for Patients With IDH-Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell TransplantationEvan C Chen, Shuli Li, Ann-Kathrin Eisfeld, et al.
Transplantation and Cellular Therapy|May 9, 2023
Long-Term Results with Thiotepa-Containing Conditioning Regimens for Autologous Stem Cell TransplantationYarden Irit Cohen, Eyal Lebel, Eran Zimran, et al.
Transplantation and Cellular Therapy|May 11, 2023
Female Reproductive Health Outcomes after Hematopoietic Cell Transplantation for Sickle Cell Disease: Is Reduced Intensity Better Than Myeloablative Conditioning?Lillian R Meacham, Sobenna George, Anirudh Veludhandi, et al.
Transplantation and Cellular Therapy|May 14, 2023
Tocilizumab for Cytokine Release Syndrome Management After Haploidentical Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide-Based Graft-Versus-Host Disease ProphylaxisJanny M Yao, Salman Otoukesh, Hanna Kim, et al.
Transplantation and Cellular Therapy|August 24, 2022
Ocular Chronic Graft-versus-Host Disease and Its Relation to Other Organ Manifestations and Outcomes after Allogeneic Hematopoietic Cell TransplantationHelene Jeppesen, Lars Klingen Gjærde, Jens Lindegaard, et al.
Transplantation and Cellular Therapy|August 11, 2022
Defibrotide Shows Efficacy in the Prevention of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective StudyYves Chalandon, Anne-Claire Mamez, Federica Giannotti, et al.
Transplantation and Cellular Therapy|August 16, 2022
High Risk of Recurrence of Malignancy Noted in Four-day rATG Regimen After Allogeneic PBSCT From Matched Sibling DonorsNan Wang, Haitao Wang, Shu Fang, et al.
Transplantation and Cellular Therapy|August 15, 2022
Modified High-Dose versus High-Dose Melphalan Conditioning in Older Patients Undergoing Autologous Stem Cell Transplantation for Immunoglobulin Light Chain AmyloidosisHamza Hassan, Karina Verma, Grace Ferri, et al.
Transplantation and Cellular Therapy|August 15, 2022
The Cost-Effectiveness of Axicabtagene Ciloleucel as Second-Line Therapy in Patients with Large B-Cell Lymphoma in the United States: An Economic Evaluation of the ZUMA-7 TrialMiguel-Angel Perales, John Kuruvilla, Julia Thornton Snider, et al.
Transplantation and Cellular Therapy|August 15, 2022
Pneumococcal Conjugate Vaccine Does Not Induce Humoral Response When Administrated Within the Six Months After CD19 CAR T-Cell TherapyDasom Lee, Aryanna I Jordan, Meghan A Menges, et al.
Pageof 181